Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV - Related Studies

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

This study is ongoing, but not recruiting participants.

Study NCT00080119. Last updated on November 19, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections
		Tuberculosis
		Pneumocystis Jirovecii Pneumonia

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Pneumonia

3	More general conditions related to this trial
		Actinomycetales Infections
		Bacterial Infections
		Gram-Positive Bacterial Infections
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Lung Diseases
		Mycobacterium Infections
		Respiratory Tract Diseases
		Respiratory Tract Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Isoniazid
		Sulfamethoxazole/Trimethoprim

5	Additional drug interventions recognized in this trial
		Sulfamethoxazole
		Trimethoprim
		Trimethoprim-Sulfamethoxazole Combination

6	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Anti-Infective Agents, Urinary
		Antilipemic Agents
		Antimalarials
		Antimetabolites
		Antiparasitic Agents
		Antiprotozoal Agents
		Antitubercular Agents
		Enzyme Inhibitors
		Fatty Acid Synthesis Inhibitors
		Folic Acid Antagonists
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Renal Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)
		Comprehensive International Program of Research on AIDS
		Secure the Future Foundation